M0036155100: Stryker Target 3D Detachable Embolization Coil 5mm x 10cm

Sign in to add this product to your favorites!
| Price: | $305.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 13 hours 46 minutes and choose overnight shipping at checkout. |
Additional Details
Stryker Neurovascular Target 3D Detachable Embolization Coil
The Stryker Neurovascular Target 3D Detachable Coil is a sterile, implantable embolization coil designed to obstruct or occlude blood flow within vascular abnormalities. Its complex three-dimensional configuration alternates large and small loops to create a stable framework within the treatment site, supporting consistent framing and subsequent coil placement.
The small loops add body and help maintain the coil’s shape, while the larger loops contact the vessel or aneurysm wall to enhance stability. The coil rotates approximately 90 degrees at each small loop to develop its three-dimensional configuration during deployment.
- Product Type: Detachable Embolization Coil
- Product Family: Target Detachable Coils
- Coil Configuration: Three-Dimensional
- Primary Function: Vascular Occlusion and Embolization
- Applications: Intracranial Aneurysms, Arteriovenous Malformations, Arteriovenous Fistulae and Peripheral Vascular Embolization
- Placement Role: Framing
- Deployment: Endovascular
- Detachment System: Stryker Neurovascular InZone Detachment System
- Implantable
- Single-Use
Sterilization
- Device Packaged as Sterile: Yes
- Requires Sterilization Prior to Use: No
AccessGUDID Info
- FDA Product Code: HCG
- FDA Product Code Name: DEVICE, NEUROVASCULAR EMBOLIZATION
- FDA Product Code: KRD
- FDA Product Code Name: Device, Vascular, for Promoting Embolization
- GMDN Term Code: 60940
- GMDN Term Name: Neurovascular embolization coil
- GMDN Term Description: A non-bioabsorbable, implantable device intended to induce a neurovascular thrombosis to treat an intracranial aneurysm and/or neurovascular arteriovenous malformation (AVM); it may also be intended to treat non-neurovascular malformations. It is in the form of a metal [e.g., platinum alloy] or metal/synthetic polymer wire which coils upon deployment within the aneurysm/vasculature; it is typically pre-attached to a nonimplantable delivery wire. Disposable devices associated with implantation (e.g., delivery wire, catheter) may be included.
Manufacturer
Stryker Neurovascular is a global leader in stroke care and neurointervention, offering a comprehensive portfolio of devices for the treatment of ischemic and hemorrhagic stroke. Their product lines include the Trevo Retriever for mechanical thrombectomy, the AXS Infinity and AXS Catalyst distal access catheters, and the Target coil family for aneurysm embolization. Stryker also offers the Neuroform Atlas and LVIS stents for stent-assisted coiling, as well as the Surpass Evolve flow diverter for treating large or wide-neck intracranial aneurysms. With a focus on rapid innovation, clinical outcomes, and stroke workflow optimization, Stryker Neurovascular continues to shape the future of minimally invasive neurosurgery.
IN-DATE